ClinConnect ClinConnect Logo
Search / Trial NCT06878911

Clinical Validation of Nerveblox, an Artificial Intelligence Software to Support Ultrasound-Guided Regional Anesthesia Procedures

Launched by SMART ALFA TEKNOLOJI SAN. VE TIC. A.S. · Mar 10, 2025

Trial Information

Current as of April 26, 2025

Completed

Keywords

Artificial Intelligence Regional Anesthesia

ClinConnect Summary

This study aims to validate the performance of AI technology in regional anesthesia through a clinical evaluation conducted on the U.S. population.

Data collection method and Analysis:

A total of 40 healthy subjects were enrolled and scanned by three different expert anesthesiologists. Twelve different peripheral nerve and plane block regions supported by the Nerveblox software were scanned bilaterally. Each participant spent approximately 30 minutes in the ultrasound scanning session, with each ultrasound clip lasting 10 seconds.

Age, gender, weight, and height data were collected and r...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • In good general health
  • Exclusion Criteria:
  • Pregnancy
  • Inability to lie to flat
  • Any complaint or anatomical deformity on the regions to be scanned

About Smart Alfa Teknoloji San. Ve Tic. A.S.

Smart Alfa Teknoloji San. ve Tic. A.Ş. is an innovative clinical trial sponsor focused on advancing medical research and development through cutting-edge technology solutions. With a commitment to enhancing patient outcomes and streamlining trial processes, the company leverages its expertise in data analytics, digital health, and regulatory compliance to facilitate efficient and effective clinical studies. Smart Alfa is dedicated to fostering partnerships with healthcare professionals and institutions to drive forward-thinking approaches in the biopharmaceutical sector, ensuring the development of safe and effective therapies for a range of medical conditions.

Locations

Brooklyn, New York, United States

Patients applied

0 patients applied

Trial Officials

Gary Scott Shwartz, M.D.

Principal Investigator

AABP Integrative Pain Care and Wellness Clinic, Brooklyn

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported